Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Hematology & Oncology
Published in: Journal of Hematology & Oncology 1/2011

Open Access 01-12-2011 | Letter to the Editor

Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group

Authors: Takeshi Chihara, Naoki Wada, Junichiro Ikeda, Shigeki Fujita, Yumiko Hori, Hiroyasu Ogawa, Haruo Sugiyama, Shosaku Nomura, Itaru Matsumura, Masayuki Hino, Yuzuru Kanakura, Eiichi Morii, Katsuyuki Aozasa

Published in: Journal of Hematology & Oncology | Issue 1/2011

Login to get access

Excerpt

Dear Editor: …
Literature
1.
Swerdlow SH, Campo E, Harris NL: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 2008, Lyon, France: IARC Press, 4
2.
Au WY, Shek TW, Kwong YL: Epstein-Barr virus-related intravascular lymphomatosis. Am J Surg Pathol. 2000, 24 (2): 309-10. 10.1097/00000478-200002000-00028.CrossRefPubMed
3.
Lymphoma Study Group of Japanese Patologists: The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Pathol Int. 2000, 50 (9): 696-702. 10.1046/j.1440-1827.2000.01108.x.CrossRef
4.
Sukpanichnant S, Visuthisakchai S: Intravascular lymphomatosis: a study of 20 cases in Thailand and a review of the literature. Clin Lymphoma Myeloma. 2006, 6 (4): 319-28. 10.3816/CLM.2006.n.007.CrossRefPubMed
5.
Murase T, Yamaguchi M, Suzuki R: Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5. Blood. 2007, 109 (2): 478-85. 10.1182/blood-2006-01-021253. Epub 2006 Sep 19CrossRefPubMed
6.
Ferreri AJ, Campo E, Seymour JF: Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol. 2004, 127 (2): 173-83. 10.1111/j.1365-2141.2004.05177.x. ReviewCrossRefPubMed
7.
Murase T, Nakamura S: An Asian variant of intravascular lymphomatosis: an updated review of malignant histiocytosis-like B-cell lymphoma. Leuk Lymphoma. 1999, 33 (5-6): 459-73. Review. Erratum in: Leuk Lymphoma 1999 Jun;34(1-2):following 206PubMed
8.
Murase T, Nakamura S, Kawauchi K: An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol. 2000, 111 (3): 826-34. 10.1046/j.1365-2141.2000.02426.x.PubMed
9.
Murase T, Tomita Y, Nakamura S: Clinicopathologic features of intravascular large B-cell lymphoma in Japan: review of the special reference to the Asian variant. Rinsho Ketsueki. 2002, 43 (1): 5-11. Review. JapanesePubMed
10.
Murase T: Asian variant of intravascular large B-cell lymphoma: still a diagnostic enigma?. Intern Med. 2002, 41 (12): 1099-100. 10.2169/internalmedicine.41.1099.CrossRefPubMed
11.
Matsuda T, Marugame T, Kamo K: Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Japanese Journal of Clinical Oncology. 2009, 39: 850-8. 10.1093/jjco/hyp106.CrossRefPubMed
Metadata
Title
Frequency of intravascular large B-cell lymphoma in Japan: Study of the Osaka Lymphoma Study Group
Authors
Takeshi Chihara
Naoki Wada
Junichiro Ikeda
Shigeki Fujita
Yumiko Hori
Hiroyasu Ogawa
Haruo Sugiyama
Shosaku Nomura
Itaru Matsumura
Masayuki Hino
Yuzuru Kanakura
Eiichi Morii
Katsuyuki Aozasa
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of Hematology & Oncology / Issue 1/2011
Electronic ISSN: 1756-8722
DOI
https://doi.org/10.1186/1756-8722-4-14

Other articles of this Issue 1/2011

Journal of Hematology & Oncology 1/2011 Go to the issue

Letter to the Editor

Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

Research

Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer

Research

Effect of a structurally modified human granulocyte colony stimulating factor, G-CSFa, on leukopenia in mice and monkeys

Review

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP

Short report

Altered protein expression in serum from endometrial hyperplasia and carcinoma patients

Case report

Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits